Therapeutic potential of boron-containing compounds

Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

(2009) Tsutomu Akama et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes

(2009) Rajesh Gupta et al.   CURRENT DRUG TARGETS

Potent inhibitors of HCV-NS3 protease derived from boronic acids

(2008) Srikanth Venkatraman et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus

(2008) G. Garcia-Soria et al.   DIABETES OBESITY & METABOLISM

Novel β-lactam antibiotics and inhibitor combinations

(2008) Matteo Bassetti et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Dipeptide Boronic Acid Inhibitors of Dipeptidyl Peptidase IV: Determinants of Potency and in Vivo Efficacy and Safety

(2008) Beth A. Connolly et al.   JOURNAL OF MEDICINAL CHEMISTRY

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)

(2008) Roger Henriksson et al.   RADIOTHERAPY AND ONCOLOGY

Structure-based optimization of cephalothin-analogue boronic acids as β-lactamase inhibitors

(2007) Stefania Morandi et al.   BIOORGANIC & MEDICINAL CHEMISTRY